Trial Condition(s):

Erectile Dysfunction

Evaluating the efficacy and safety of vardenafil in subjects with erectile dysfunction and hypertension

Bayer Identifier:

100539

ClinicalTrials.gov Identifier:

NCT00668005

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Assess efficacy of Vardenafil in patients erectile dysfunction and high blood pressure

Inclusion Criteria
- Men >/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement,
 - Arterial hypertension adequately controlled
 - Stable sexual relationship for > 6 month
Exclusion Criteria
- Primary hypoactive sexual desire
 - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
 - Nitrate therapy

Trial Summary

Enrollment Goal
388
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design